Page last updated: 2024-09-04

nepafenac and Central Serous Chorioretinopathy

nepafenac has been researched along with Central Serous Chorioretinopathy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chronopoulos, A; Consigli, A; Kakkassery, V; Papanastasiou, A; Roquelaure, D; Schutz, JS; Thumann, G; Wuarin, R	1

Other Studies

1 other study(ies) available for nepafenac and Central Serous Chorioretinopathy

Article	Year
Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy. Optometry and vision science : official publication of the American Academy of Optometry, 2019, Volume: 96, Issue:7 Topics: Acetazolamide; Administration, Ophthalmic; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Carbonic Anhydrase Inhibitors; Central Serous Chorioretinopathy; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Male; Middle Aged; Phenylacetates; Pilot Projects; Retinal Pigment Epithelium; Subretinal Fluid; Tomography, Optical Coherence; Visual Acuity	2019

Article

Year

Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy.

Optometry and vision science : official publication of the American Academy of Optometry, 2019, Volume: 96, Issue:7

Topics: Acetazolamide; Administration, Ophthalmic; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Carbonic Anhydrase Inhibitors; Central Serous Chorioretinopathy; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Male; Middle Aged; Phenylacetates; Pilot Projects; Retinal Pigment Epithelium; Subretinal Fluid; Tomography, Optical Coherence; Visual Acuity

2019